Scientists from Human Cell Design participated in the 5th European Incretin Study Group meeting in Cambridge (UK). During the event, our team presented how our rapid and high-resolution insulin secretion and cAMP assays can help scientists increase the throughput of their GLP-1/GIP receptor agonist evaluation.

This Study Group aims to provide a dedicated platform for researchers interested in incretin and related hormones. Its goal is to foster collaboration among academia, hospitals, and industry to advance understanding of incretin physiology, its role in metabolic diseases, and therapeutic strategies.

Discover our poster titled: “Increased resolution and throughput of GLP-1 receptor agonist evaluation using cAMP measurement in EndoC-βH5® human beta cells”.

See the poster

Comments are closed.